|
Volumn 111, Issue 3, 2013, Pages 184-186
|
Tranexomic acid used before caesarean section reduces blood loss based on pre- and postoperative hemoglobin level: A case-control study
|
Author keywords
Caesarean section; Tranexamic acid
|
Indexed keywords
HEMOGLOBIN;
METHYLERGOMETRINE;
OXYTOCIN;
TRANEXAMIC ACID;
ANTIFIBRINOLYTIC AGENT;
ABSENCE OF SIDE EFFECTS;
ADULT;
APGAR SCORE;
ARTICLE;
BLEEDING;
CASE CONTROL STUDY;
CESAREAN SECTION;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
KIDNEY FUNCTION TEST;
LIVER FUNCTION TEST;
POSTPARTUM HEMORRHAGE;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
URINALYSIS;
CONTROLLED CLINICAL TRIAL;
FOLLOW UP;
METABOLISM;
METHODOLOGY;
NEWBORN;
OPERATIVE BLOOD LOSS;
POSTOPERATIVE PERIOD;
PREGNANCY;
PREOPERATIVE PERIOD;
TREATMENT OUTCOME;
ADULT;
ANTIFIBRINOLYTIC AGENTS;
BLOOD LOSS, SURGICAL;
CASE-CONTROL STUDIES;
CESAREAN SECTION;
FEMALE;
FOLLOW-UP STUDIES;
HEMOGLOBINS;
HUMANS;
INFANT, NEWBORN;
POSTOPERATIVE PERIOD;
PREGNANCY;
PREOPERATIVE PERIOD;
PROSPECTIVE STUDIES;
TRANEXAMIC ACID;
TREATMENT OUTCOME;
|
EID: 84876010541
PISSN: 00195847
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (3)
|